Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Petmed Express stock

PETS
US7163821066
121843

Price

4.53
Today +/-
-0.16
Today %
-3.70 %
P

Petmed Express stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Petmed Express stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Petmed Express stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Petmed Express stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Petmed Express's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Petmed Express Stock Price History

DatePetmed Express Price
11/18/20244.53 undefined
11/15/20244.70 undefined
11/14/20245.07 undefined
11/13/20245.15 undefined
11/12/20245.17 undefined
11/11/20245.42 undefined
11/8/20245.56 undefined
11/7/20245.73 undefined
11/6/20244.22 undefined
11/5/20244.27 undefined
11/4/20244.22 undefined
11/1/20244.19 undefined
10/31/20244.10 undefined
10/30/20244.03 undefined
10/29/20244.08 undefined
10/28/20244.15 undefined
10/25/20243.87 undefined
10/24/20243.85 undefined
10/23/20243.90 undefined
10/22/20244.10 undefined
10/21/20243.92 undefined

Petmed Express Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Petmed Express, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Petmed Express from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Petmed Express’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Petmed Express. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Petmed Express’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Petmed Express’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Petmed Express’s growth potential.

Petmed Express Revenue, EBIT and net profit per share

DatePetmed Express RevenuePetmed Express EBITPetmed Express Net Income
2027e294.51 M undefined1.75 M undefined2.32 M undefined
2026e271.51 M undefined-2.48 M undefined-737,562 undefined
2025e262.69 M undefined966,450 undefined1.79 M undefined
2024281.06 M undefined-8.16 M undefined-7.46 M undefined
2023256.9 M undefined-1.4 M undefined200,000 undefined
2022273.4 M undefined25.7 M undefined21.1 M undefined
2021309.2 M undefined37.6 M undefined30.6 M undefined
2020284.1 M undefined31 M undefined25.9 M undefined
2019283.4 M undefined46.2 M undefined37.7 M undefined
2018273.8 M undefined52.1 M undefined37.3 M undefined
2017249.2 M undefined37.5 M undefined23.8 M undefined
2016234.7 M undefined32.4 M undefined20.6 M undefined
2015229.4 M undefined29.3 M undefined17.5 M undefined
2014233.4 M undefined28.2 M undefined18 M undefined
2013227.8 M undefined27 M undefined17.2 M undefined
2012238.3 M undefined26 M undefined16.7 M undefined
2011231.6 M undefined33 M undefined20.9 M undefined
2010238.3 M undefined40.5 M undefined26 M undefined
2009219.4 M undefined34.2 M undefined23 M undefined
2008188.3 M undefined28 M undefined20 M undefined
2007162.2 M undefined21.5 M undefined14.4 M undefined
2006137.6 M undefined18.1 M undefined12.1 M undefined
2005108.4 M undefined12.5 M undefined8 M undefined

Petmed Express Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
101410325594108137162188219238231238227233229234249273283284309273256281262271294
-40.00-28.57220.0071.8870.9114.8926.8518.2516.0516.498.68-2.943.03-4.622.64-1.722.186.419.643.660.358.80-11.65-6.239.77-6.763.448.49
40.0042.8630.0040.6341.8240.4339.8139.4239.5139.3638.8138.2436.3633.6133.9233.0533.1932.4831.7335.5333.5728.5228.8028.5727.7327.7629.7728.7826.53
4631323384354647485918480777776767997958189787178000
0-1-2035812142023262016171817202337372530210-7102
--100.00--66.6760.0050.0016.6742.8615.0013.04-23.08-20.006.255.88-5.5617.6515.0060.87--32.4320.00-30.00---114.29--
-----------------------------
-----------------------------
5.36.49.919.720.723.723.824.224.324.323.522.722.620.7202020.120.320.420.420.520.120.120.420.320.4000
-----------------------------
Details

Keystats

Revenue and Growth

The Petmed Express Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Petmed Express is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                 
0.60.40.713.312.723.239.42530.153.159.857.133.633.851.237.658.777.9100.5103.8118.7111.1104.155.3
0.20.20.30.71.11.81.21.41.62.92.121.61.41.81.91.71.82.32.53.82.61.91.73.28
000000000300300600200000300080060000000
1.80.62.34.311.211.21516.117.926.829.125.126.231.635.725.125.620.223.321.417.934.432.51928.56
0.400.10.50.20.20.61.10.71.51.922.42.12.91.42.410.91.43.55.55.56.66.51
31.23.46.515.825.9405845.261.686.589.587.568.774.279.667.681.7105.2126.4129161.2151131.493.65
3.33.21.11.51.71.31.521.95.14.43.42.62.11.31.620.930.228.727.125.425.524.526.228.09
0000000024.714.412.412.40000000000000
0000000000000000000000000
0000.40.40.40.40.40.40.90.90.90.90.90.90.90.90.90.90.90.90.90.95.916.5
00000000000000000000000026.66
0.10.10.10.80.60.60.80.91.200001.420.80.90000000.64.99
3.43.31.22.72.72.32.73.328.220.417.716.73.54.44.23.322.731.129.62826.326.425.432.776.24
6.44.54.69.218.528.242.761.373.482104.2106.29173.178.482.990.3112.8134.8154.4155.3187.6176.4164.1169.88
                                                 
00000000000000000000000030
4.66.56.57.39.912.113.415.28.402.60001.63.14.96.89.412.53.87.111.718.325.15
-3-5.8-5-1.74.112.124.238.658.675.294.397.181.16468.672.378.386.5106.3122.2126.2134.1130.5105.571.56
000000000-0.2-0.1-0.1000-0.1000000000
0000000000000000000000000
1.60.71.55.61424.237.653.8677596.89781.16470.275.383.293.3115.7134.7130141.2142.2123.896.73
1.31.52.72.63.32.73.15.94.44.84.86.56.66.55.85.2515.215.316.319.739.527.525.237.02
0.1000.60.70.611.31.92.22.32.52.82.12.121.92.32.62.145.25.11031.07
0.10.300.20.40.610.20.200000.40.30.30.10.90.20.20.70.20.61.34.07
0000000000000000000000000
11.90.10.10.100000000000000000000
2.53.72.83.54.53.95.17.46.577.199.498.27.5718.418.118.624.444.933.236.572.16
1.800.30.1000000000000000000000
00000000000.20.30.50.20.1001.111.111.30.900
0.400000000000000000000003.81
2.200.30.10000000.20.30.50.20.1001.111.111.30.93.81
4.73.73.13.64.53.95.17.46.577.39.39.99.28.37.5719.519.119.725.446.234.140.373.15
6.34.44.69.218.528.142.761.273.582104.1106.39173.278.582.890.2112.8134.8154.4155.4187.4176.3164.1169.88
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Petmed Express provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Petmed Express's financial health and stability.

Assets

Petmed Express's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Petmed Express must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Petmed Express after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Petmed Express's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (k)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0-1-2035812142022262016171717202337372530210
0000000000011110001222223
0000000000000000001,00000000-1,000
0110-2-5-1-20-2-10050-6-610-217-4173-918
00000000133344334345656913
0000000000000000000000000
0000023691016141291010101211181171064
00-10018101619142730201313322147374538401827
-2000-1000-10-3-100000-20-1000-2-2-1-5
-2001-10-11-11-179111-1011-500-4-1000-2-2-1-10
000200-11-11-169142-1012-50015000000-5
0000000000000000000000000
1,00000-1,000000000000000000000000
001002110-8-160-11-23-3000000-11000
201-101110-8-16-5-22-34-36-13-13-14-15-17-21-33-22-24-24
-------------------------
00000000000-6-10-10-31-13-13-14-15-17-21-21-22-24-24
000002-20019923-3-2-280172211922314-7-7
-2.85-0.87-1.28-0.08-0.140.378.189.5215.5318.8811.2826.6429.4319.6812.6613.4631.120.9236.636.6844.5236.5337.6516.7522.54
0000000000000000000000000

Petmed Express stock margins

The Petmed Express margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Petmed Express. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Petmed Express.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Petmed Express's sales revenue. A higher gross margin percentage indicates that the Petmed Express retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Petmed Express's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Petmed Express's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Petmed Express's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Petmed Express. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Petmed Express's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Petmed Express Margin History

Petmed Express Gross marginPetmed Express Profit marginPetmed Express EBIT marginPetmed Express Profit margin
2027e27.98 %0.59 %0.79 %
2026e27.98 %-0.91 %-0.27 %
2025e27.98 %0.37 %0.68 %
202427.98 %-2.9 %-2.66 %
202327.64 %-0.54 %0.08 %
202228.57 %9.4 %7.72 %
202129.08 %12.16 %9.9 %
202028.58 %10.91 %9.12 %
201933.63 %16.3 %13.3 %
201835.72 %19.03 %13.62 %
201731.82 %15.05 %9.55 %
201632.51 %13.8 %8.78 %
201533.26 %12.77 %7.63 %
201433.25 %12.08 %7.71 %
201333.85 %11.85 %7.55 %
201233.66 %10.91 %7.01 %
201136.27 %14.25 %9.02 %
201038.56 %17 %10.91 %
200938.88 %15.59 %10.48 %
200839.41 %14.87 %10.62 %
200739.83 %13.26 %8.88 %
200639.46 %13.15 %8.79 %
200540.31 %11.53 %7.38 %

Petmed Express Stock Sales Revenue, EBIT, Earnings per Share

The Petmed Express earnings per share therefore indicates how much revenue Petmed Express has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Petmed Express earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Petmed Express's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Petmed Express’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Petmed Express's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Petmed Express Revenue, EBIT and net profit per share

DatePetmed Express Sales per SharePetmed Express EBIT per sharePetmed Express Earnings per Share
2027e14.26 undefined0 undefined0.11 undefined
2026e13.14 undefined0 undefined-0.04 undefined
2025e12.71 undefined0 undefined0.09 undefined
202413.78 undefined-0.4 undefined-0.37 undefined
202312.66 undefined-0.07 undefined0.01 undefined
202213.4 undefined1.26 undefined1.03 undefined
202115.38 undefined1.87 undefined1.52 undefined
202014.13 undefined1.54 undefined1.29 undefined
201913.82 undefined2.25 undefined1.84 undefined
201813.42 undefined2.55 undefined1.83 undefined
201712.22 undefined1.84 undefined1.17 undefined
201611.56 undefined1.6 undefined1.01 undefined
201511.41 undefined1.46 undefined0.87 undefined
201411.67 undefined1.41 undefined0.9 undefined
201311.39 undefined1.35 undefined0.86 undefined
201211.51 undefined1.26 undefined0.81 undefined
201110.25 undefined1.46 undefined0.92 undefined
201010.5 undefined1.78 undefined1.15 undefined
20099.34 undefined1.46 undefined0.98 undefined
20087.75 undefined1.15 undefined0.82 undefined
20076.67 undefined0.88 undefined0.59 undefined
20065.69 undefined0.75 undefined0.5 undefined
20054.55 undefined0.53 undefined0.34 undefined

Petmed Express business model

Petmed Express Inc. is a US company that was founded in 1996 and is based in Delray Beach, Florida. The company is best known by its trade name - 1800-PetMeds. It is one of the largest online pharmacies for pet supplies and offers a variety of products such as medications, supplements, food, toys, and accessories for pets. The company's history is rooted in the emergence of online commerce. In 1996, Marc Puleo founded the company when he realized that there was no pharmacy specializing in pet supplies and wanted to capitalize on the potential of the then-new medium - the internet - to build a nationwide company. In the early years, 1800-PetMeds worked hard to bring awareness of the company to consumers and veterinarians through the internet. The company sought and found ways to gain customer trust and differentiate itself from traditional veterinary practices. 1800-PetMeds offered affordable medications and a wide range of pet products. In this way, Petmed Express Inc. became a pioneering company in e-commerce, revolutionizing how veterinarians and their patients gain access to products. Over the years, the company built long-standing business relationships with leading manufacturers of pet products and veterinarians to expand its offerings. 1800-PetMeds' business model is based on a simple concept - providing pet products and medications at lower prices than local veterinarians. The company operates a wide range of platforms that make it easy for users to find the desired product, with user-friendly service features for customers. One of the major advantages for consumers is that they can easily place their orders online or through a phone call. This allows them to have the necessary medications and treatments for their pets directly delivered to their homes, avoiding potential stress factors that a visit to the veterinarian would trigger. Petmed Express offers a wide range of products for pets, including medications for various types of animal diseases and injuries. Special preparations are available for many conditions in the areas of heart, digestion, kidneys and metabolism, skin, as well as anxiety and stress management. In addition, 1800-PetMeds offers subsidized medications for older pets or those with chronic illnesses. In addition to prescription medications and supplements, Petmed Express also offers a wide range of pet supplies. This includes dog food, cat food, treats, toys, beds, grooming and hygiene items. Petmed Express also has a unique program that is not found in e-commerce called the 'Petscription' program. This is a program where members have the advantage of obtaining medications prescribed directly by veterinarians at a lower price than at their local veterinarians. This program is a major competitive advantage for 1800-PetMeds. In recent years, the company has made significant progress in improving accessibility. The establishment of a mobile shopping center in various locations in the US and the program to support animal welfare organizations have promoted the growth of Petmed. Thanks to its decades of experience and numerous partnerships in the animal health industry, Petmed Express has established a solid position in the industry. The company is one of the largest online pharmacies for pets in the US and is known for its dedicated team of professionals who are available 24/7 to assist customers with any questions and concerns. Overall, Petmed Express is an innovative company that has made a name for itself through its business model, wide range of products, and commitment to the protection and health of animals. Petmed Express Inc. has experienced tremendous growth in recent years and remains on track to continue growing and continuing its commitment to animal health and wellbeing. Petmed Express is one of the most popular companies on Eulerpool.com.

Petmed Express SWOT Analysis

Strengths

Petmed Express Inc. has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and recognition in the pet medication industry. This reputation has been built through years of providing quality and reliable pet medications and services to its customers. Additionally, Petmed Express Inc. has a wide range of products, offering a comprehensive selection of medications and supplies for pets. This diverse product portfolio allows the company to cater to the varied needs of pet owners.

Weaknesses

Petmed Express Inc. also faces certain weaknesses that may hinder its growth and profitability. One key weakness is the company's limited geographical presence. While Petmed Express Inc. operates nationally, it may not have the same level of reach and accessibility as some of its competitors. Additionally, the company heavily relies on third-party manufacturers and suppliers for its products. This dependence on external sources may lead to potential disruptions in the supply chain or quality control issues.

Opportunities

There are several opportunities for Petmed Express Inc. to explore and expand its business. One significant opportunity is the growing pet ownership and pet healthcare market. As more individuals are adopting pets and becoming pet owners, there is an increased demand for pet medications and related services. By capitalizing on this trend, Petmed Express Inc. can tap into a larger customer base and potentially increase its market share. Additionally, the company can also consider expanding its product offerings to include specialized pet care services, such as grooming or training, to cater to the evolving needs of pet owners.

Threats

Petmed Express Inc. faces various threats that may pose challenges to its operations and position in the market. One major threat is the presence of intense competition in the pet medication industry. There are numerous competitors, including traditional brick-and-mortar stores and online retailers, offering similar products and services. This competitive landscape may lead to price wars and margin pressures. Moreover, the industry is subject to stringent regulations and compliance requirements, which may increase operational costs and create barriers to entry for new players.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Petmed Express Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Petmed Express historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Petmed Express shares outstanding

The number of shares was Petmed Express in 2023 — This indicates how many shares 20.3 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Petmed Express earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Petmed Express's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Petmed Express’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Petmed Express's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Petmed Express stock splits

In Petmed Express's history, there have been no stock splits.

Petmed Express dividend history and estimates

In 2023, Petmed Express paid a dividend amounting to 1.2 USD. Dividend means that Petmed Express distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Petmed Express provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Petmed Express’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Petmed Express's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Petmed Express Dividend History

DatePetmed Express Dividend
2027e0.11 undefined
2026e-0.03 undefined
2025e0.09 undefined
20231.2 undefined
20221.2 undefined
20211.18 undefined
20201.11 undefined
20191.08 undefined
20181.04 undefined
20170.79 undefined
20160.75 undefined
20150.71 undefined
20140.68 undefined
20130.64 undefined
20121.6 undefined
20110.5 undefined
20100.45 undefined
20090.2 undefined

Petmed Express dividend payout ratio

In 2023, Petmed Express had a payout ratio of 93.02%. The payout ratio indicates the percentage of the company's profits that Petmed Express distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Petmed Express represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Petmed Express could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Petmed Express's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Petmed Express Payout Ratio History

DatePetmed Express Payout ratio
2027e97.71 %
2026e96.54 %
2025e101.25 %
202495.35 %
202393.02 %
2022115.38 %
202177.63 %
202086.05 %
201958.7 %
201857.14 %
201767.52 %
201673.53 %
201581.61 %
201475.56 %
201374.42 %
2012200 %
201154.35 %
201039.47 %
200920.41 %
200893.02 %
200793.02 %
200693.02 %
200593.02 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Petmed Express.

Petmed Express latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2024-0.06 0.11  (296.08 %)2025 Q2
6/30/2024-0.09 0.18  (296.08 %)2025 Q1
3/31/2024-0.07 -0.25  (-250.14 %)2024 Q4
12/31/2023-0.01 -0.1  (-880.39 %)2024 Q3
9/30/2023-0.01 (100 %)2024 Q2
6/30/20230.07 -0.04  (-153.48 %)2024 Q1
3/31/20230.14 -0.25  (-279.34 %)2023 Q4
12/31/20220.2 (-100 %)2023 Q3
9/30/20220.26 0.13  (-49.02 %)2023 Q2
6/30/20220.26 0.14  (-45.82 %)2023 Q1
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the Petmed Express stock

Eulerpool World ESG Rating (EESG©)

43/ 100

🌱 Environment

8

👫 Social

39

🏛️ Governance

81

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees70
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Petmed Express shareholders

%
Name
Stocks
Change
Date
6.26957 % Hotchkis and Wiley Capital Management, LLC1,295,293238,5436/30/2024
6.12086 % Renaissance Technologies LLC1,264,569-318,2156/30/2024
5.23260 % The Vanguard Group, Inc.1,081,055-105,4306/30/2024
2.93529 % Federated MDTA LLC606,430213,9036/30/2024
2.86271 % AQR Capital Management, LLC591,435-91,5966/30/2024
2.65782 % BlackRock Institutional Trust Company, N.A.549,106-1,079,1706/30/2024
2.55566 % Galante (Moises Tache)528,000528,0004/17/2024
2.38245 % Campos (sandra Yvette)492,2157,5006/12/2024
2.10960 % Twin Oaks Partners435,84406/30/2024
2.02690 % Arrowstreet Capital, Limited Partnership418,758-145,1356/30/2024
1
2
3
4
5
...
10

Petmed Express Executives and Management Board

Ms. Christine Chambers(46)
Petmed Express Chief Financial Officer, Treasurer, Company Secretary
Compensation 651,481
Mr. Mathew Hulett(53)
Petmed Express President, Chief Executive Officer, Director (since 2021)
Compensation 534,119
Ms. Diana Purcel(57)
Petmed Express Independent Director
Compensation 251,069
Dr. Gian Fulgoni(75)
Petmed Express Independent Director
Compensation 218,200
Ms. Leslie Campbell(64)
Petmed Express Chairman of the Board (since 2018)
Compensation 203,200
1
2

Petmed Express Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer-0,340,69-0,200,470,780,43
1

Most common questions regarding Petmed Express

What values and corporate philosophy does Petmed Express represent?

Petmed Express Inc represents values of customer-centric service, trust, and quality in the pet medication industry. With a commitment to providing affordable and convenient pet medications, Petmed Express aims to ensure the well-being of pets and satisfaction of their owners. The company's corporate philosophy revolves around delivering exceptional healthcare solutions for pets, emphasizing personalized care and easy accessibility. Petmed Express prioritizes transparency, reliability, and professionalism in all its operations, striving to establish long-term relationships with customers based on trust and ethical practices.

In which countries and regions is Petmed Express primarily present?

Petmed Express Inc, also known as 1-800-PetMeds, primarily operates in the United States. As a leading provider of pet medications, the company serves customers across all regions and states within the US. With a comprehensive online platform, Petmed Express Inc offers convenient access to a wide range of affordable prescription and over-the-counter pet medications, catering to the needs of pet owners nationwide. By focusing on the US market, Petmed Express Inc has established itself as a trusted and reliable destination for pet medication needs, ensuring the well-being of pets across the country.

What significant milestones has the company Petmed Express achieved?

Petmed Express Inc has achieved several significant milestones throughout its history. The company has consistently delivered quality pet medications and supplies across the United States. It has established a strong presence in the online pet pharmacy market, catering to the increasing demand for convenient and cost-effective pet care products. Petmed Express Inc has diligently grown its customer base and created a loyal following by providing exceptional customer service. The company's commitment to pet health and wellbeing has been recognized through numerous industry awards and accolades. Overall, Petmed Express Inc has successfully carved a niche for itself in the pet pharmaceutical industry, solidifying its position as a reliable and trusted provider of pet medications and related products.

What is the history and background of the company Petmed Express?

Petmed Express Inc, commonly known as PetMeds, is a leading online pet pharmacy in the United States. Established in 1996, PetMeds has a rich history of providing convenient and affordable pet medications and supplies to pet owners across the country. With a focus on delivering exceptional customer service and high-quality products, PetMeds has built a strong reputation in the pet healthcare industry. Over the years, the company has grown exponentially and has become a trusted name among pet owners, offering a wide range of prescription and non-prescription medications, as well as pet accessories and supplements. PetMeds continues to thrive as a reliable online destination for pet health needs.

Who are the main competitors of Petmed Express in the market?

The main competitors of PetMed Express Inc in the market include companies like Chewy Inc, 1-800-PetMeds, and Petco Animal Supplies Inc.

In which industries is Petmed Express primarily active?

Petmed Express Inc, commonly known as PetMeds, primarily operates within the pet care industry. As a leading online pet pharmacy, Petmed Express Inc focuses on the distribution of prescription and non-prescription pet medications, as well as other health and wellness products for pets. With its wide range of offerings, Petmed Express Inc serves as a one-stop destination for pet owners seeking convenient access to pet supplies. While primarily active in the pet care sector, Petmed Express Inc contributes to the overall animal health industry by providing medications and products that support the well-being of beloved companions.

What is the business model of Petmed Express?

The business model of Petmed Express Inc. is focused on providing convenient and affordable pet medications and veterinary products directly to pet owners. Petmed Express operates through its website and a toll-free customer service center, allowing customers to easily order prescription and non-prescription medications, as well as other pet supplies. The company also offers free shipping on orders over a certain amount, further enhancing its value proposition to customers. By streamlining the process of obtaining pet medications, Petmed Express aims to offer a cost-effective solution for pet owners, ultimately promoting the health and well-being of their beloved pets.

What is the P/E ratio of Petmed Express 2024?

The Petmed Express P/E ratio is -12.38.

What is the P/S ratio of Petmed Express 2024?

The Petmed Express P/S ratio is 0.33.

What is the Quality Investing of Petmed Express?

The Quality Investing for Petmed Express is 1/10.

What is the revenue of Petmed Express 2024?

The Petmed Express revenue is 281.06 M USD.

How high is the profit of Petmed Express 2024?

The Petmed Express profit is -7.46 M USD.

What is the business model of Petmed Express

Petmed Express Inc is a publicly traded company that has been successfully operating in the online trade of veterinary medicines since 1996. The company is known under the names "PetMeds" and "1800PetMeds". The business model of Petmed Express is based on selling animal medications and products through the internet and phone. Customers have the opportunity to purchase a variety of products for dogs, cats, and other animals, including prescription medications, supplements, vaccines, and other health products. The company focuses on products prescribed by veterinarians. Petmed Express offers its customers a range of benefits, including fast delivery, free shipping on orders over $49.95, a loyalty program, and an easy return and refund policy. The company is also committed to offering customers the best price in the market and regularly provides special offers and discount codes. An important part of Petmed Express' business model is collaborating with veterinarians. They can refer customers to the company and receive a commission in return. The company also works with various animal organizations to support animal welfare and rescue efforts. Petmed Express also has a division called "Vetmedin" that specializes in marketing Vetmedin®, a medication for treating heart failure in dogs. This medication is only available with a prescription, and the company works closely with veterinarians to provide it to affected dogs. Another important aspect of Petmed Express is the brand "Frontline". The company is the exclusive online distribution partner for Frontline® products in the United States. Frontline® is a well-known product for combating fleas and ticks in dogs and cats. Petmed Express is headquartered in Delray Beach, Florida. The company employs around 430 employees and operates a large distribution center in Pompano Beach, Florida. In summary, Petmed Express' business model is focused on the online sale of veterinary medications and products, as well as collaborating with veterinarians. The company offers its customers a wide range of products, fast delivery, free shipping, a loyalty program, and an easy return and refund policy. Additionally, the company works closely with animal organizations and veterinarians to support animal welfare and rescue efforts.

What is the Petmed Express dividend?

Petmed Express pays a dividend of 1.2 USD distributed over 4 payouts per year.

How often does Petmed Express pay dividends?

Petmed Express pays out a dividend 4 times a year.

What is the Petmed Express ISIN?

The ISIN of Petmed Express is US7163821066.

What is the Petmed Express WKN?

The WKN of Petmed Express is 121843.

What is the Petmed Express ticker?

The ticker of Petmed Express is PETS.

How much dividend does Petmed Express pay?

Over the past 12 months, Petmed Express paid a dividend of 1.2 USD . This corresponds to a dividend yield of about 26.5 %. For the coming 12 months, Petmed Express is expected to pay a dividend of 0.09 USD.

What is the dividend yield of Petmed Express?

The current dividend yield of Petmed Express is 26.5 %.

When does Petmed Express pay dividends?

Petmed Express pays a quarterly dividend. This is distributed in the months of December, March, July, September.

How secure is the dividend of Petmed Express?

Petmed Express paid dividends every year for the past 1 years.

What is the dividend of Petmed Express?

For the upcoming 12 months, dividends amounting to 0.09 USD are expected. This corresponds to a dividend yield of 1.87 %.

In which sector is Petmed Express located?

Petmed Express is assigned to the 'Cyclical consumption' sector.

Wann musste ich die Aktien von Petmed Express kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Petmed Express from 8/18/2023 amounting to 0.3 USD, you needed to have the stock in your portfolio before the ex-date on 8/11/2023.

When did Petmed Express pay the last dividend?

The last dividend was paid out on 8/18/2023.

What was the dividend of Petmed Express in the year 2023?

In the year 2023, Petmed Express distributed 1.2 USD as dividends.

In which currency does Petmed Express pay out the dividend?

The dividends of Petmed Express are distributed in USD.

All fundamentals about Petmed Express

Our stock analysis for Petmed Express Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Petmed Express Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.